Secondaries announced 7.14.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Digital Realty Trust
Symbol: DLR
Price: Last trade $68.42
Trade Date: 7/15
Shares: 10.5 million
Underwriter(s) BofA Merrill Lynch, Morgan Stanley, Citigroup
Rating=Subscription Needed

Company: WPX Energy, Inc.
Symbol: WPX
Price: Last trade $11.12
Trade Date: 7/17
Shares: 27 million
Underwriter(s) Barclays, Tudor Pickering & Holt
Rating=Subscription Needed

Company: Ultragenyx Pharmaceutical Inc.
Symbol: RARE
Price: Last trade $126.64
Trade Date: 7/16
Shares: 1.9 million
Underwriter(s) Morgan Stanley, J.P. Morgan, Cowen
Co Manager(s) JMP Securities, Wedbush PacGrow
Rating=Subscription Needed

Company: Cymabay Therapeutics
Symbol: CBAY
Price: Last Trade $2.81
Trade Date: 7/15
Shares: 6.2 million
Underwriter(s) Piper Jaffray
Co Manager(s) LifeSci Capital LLC
Rating=Subscription Needed

Company: DBV Technologies S.A.
Symbol: DBVT
Price: Last trade $38.38
Trade Date: 7/15
Shares: 6 million ADSs
Underwriter(s) Citigroup, Morgan Stanley, Barclays, Leerink Partners
Co Manager(s) H.C. Wainwright & Co.
Rating=Subscription Needed

Company: Columbia Pipeline Partners LP-BLOCK
Symbol: CPPL
Price: Last trade $25.17
Trade Date: 7/15
Shares: 4.64 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed

Company: RedHill Biopharma Ltd.
Symbol: RDHL
Price: Last trade $17.68
Trade Date: 7/17
Shares: TBD
Underwriter(s) Nomura, Roth Capital Partners
Co Manager(s) MLV & Co., H.C. Wainwright & Co.
Rating=Subscription Needed